Updates from the Patient Recruitment Office
Help the National Institute of Allergy and Infectious Diseases fight the flu! Scientists at the National Institutes of Health (NIH) are investigating what happens in kids' immune systems after receiving a flu vaccine. Researchers are enrolling children who will be receiving the seasonal flu vaccine. This is a study where participation will take place at home. Participants will not receive any vaccinations as part of this study. Call us at the Office of Patient Recruitment at 800-411-1222 or by e-mail email@example.com. Refer to NIH Study # 000488-I.
Food allergy? NIAID researchers are seeking volunteers 2 and older who have at least one food allergy to participate in a study to better understand how food allergies affect health. Participants receive a comprehensive nutritional evaluation and meet with a dietitian for individualized counseling. Compensation for participation is provided. For more information, call NIH Clinical Center Office of Patient Recruitment at 866-444-2214 or email firstname.lastname@example.org. Refer to NIH Study # 15-I-0162.
Neurofibromatosis type 1 (NF1) is a condition that can cause changes in skin color and growth of tumors (called plexiform neurofibromas or PNs) under the skin. They can form anywhere in the body and based on their size or location, PN tumors can become visible and cause unwelcome changes in appearance that are easily visible. NCI is conducting a new study to see if NF1 patients who are treated with Selumetinib have a noticeable improvement in the appearance of their tumors. Researchers at NCI are looking for volunteers to help rate changes in the appearance of PN tumors seen in patient photos before and after treatment. This is a remote study using a smartphone or computer to complete an online questionnaire in one or two 1-hour review sessions to review photographs of patients with or without treatment to score the appearance of visible tumors. To learn more, contact the NIH Clinical Center Office of Patient Recruitment at 866-444-2214 or email email@example.com. Refer to NIH Study # 000173-C.